{
    "clinical_study": {
        "@rank": "50204", 
        "arm_group": [
            {
                "arm_group_label": "paracetamol", 
                "arm_group_type": "Active Comparator", 
                "description": "paracetamol 2 tablets1000mg PO."
            }, 
            {
                "arm_group_label": "placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "placebo 2 tablets containing Starch PO"
            }
        ], 
        "brief_summary": {
            "textblock": "It is a double blinded randomized control trial   assessing the use of Oral paracetamol in\n      managing the intrapartum pain."
        }, 
        "brief_title": "Oral Paracetamol as Preemptive Analgesia for Labor Pain", 
        "completion_date": {
            "#text": "June 2012", 
            "@type": "Actual"
        }, 
        "condition": "Labor Pain", 
        "condition_browse": {
            "mesh_term": "Labor Pain"
        }, 
        "detailed_description": {
            "textblock": "It is a double blinded randomized control trial  comparing the use of Oral paracetamol to\n      placebo in managing the intrapartum pain."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  primigravida\n\n          -  The gestational age between   37- 42 weeks\n\n          -  Not seeking analgesia\n\n          -  Singleton pregnancy\n\n          -  vertex\n\n          -  Spontaneous onset of labour\n\n          -  1st stage of labour (less than 5 cm)\n\n        Exclusion Criteria:\n\n          -  Extreme of age (below18-above 40)\n\n          -  Multiparous\n\n          -  Multiple gestation\n\n          -  Malpresentation\n\n          -  Congenital or acquired pelvic abnormalities(eg. Poliomyelitis)\n\n          -  Any medical disorder with pregnancy\n\n          -  Induction of labour\n\n          -  Advanced 1st stage > 5 cm\n\n          -  Use of any other kind of analgesia before recruitment in the study\n\n          -  Scared uterus\n\n          -  Fetal distress"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "40 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 4, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01817829", 
            "org_study_id": "OPPALP", 
            "secondary_id": "Personal"
        }, 
        "intervention": [
            {
                "arm_group_label": "paracetamol", 
                "description": "500 mg oral tablet", 
                "intervention_name": "paracetamol", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "placebo", 
                "intervention_name": "placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Acetaminophen"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "March 21, 2013", 
        "number_of_arms": "2", 
        "official_title": "Oral Paracetamol as Preemptive Analgesia for Labor Pain", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "Egypt: Institutional Review Board", 
                "United States: Food and Drug Administration"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "June 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "To document the efficacy of oral paracetamol, in pregnant women in labor, as demonstrated by the degree of pain relief and need for additional analgesia during the labor process and the early postpartum period.", 
            "measure": "Efficacy", 
            "safety_issue": "No", 
            "time_frame": "intrapartum"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01817829"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Ain Shams University", 
            "investigator_full_name": "Ahmed Elsayed Hassan Elbohoty", 
            "investigator_title": "Dr", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "To document safety and evaluate adverse events recorded during the study either maternal or fetal.", 
                "measure": "Safety", 
                "safety_issue": "Yes", 
                "time_frame": "Start of medication till 24 hours postpartum"
            }, 
            {
                "description": "To assess the effect of the duration of labor.", 
                "measure": "Duration of labor", 
                "safety_issue": "No", 
                "time_frame": "Start of medication till delivery of fetus."
            }
        ], 
        "source": "Ain Shams University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ain Shams University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }
}